tiprankstipranks
Advertisement
Advertisement

CBLL Stock Latest News

Ceribell Expands Board, Adds Two New Directors
Company AnnouncementsCeribell Expands Board, Adds Two New Directors
4d ago
8K
CBLL
Ceribell Announces Director Elections at 2026 Annual Meeting
PremiumCompany Announcements
Ceribell Announces Director Elections at 2026 Annual Meeting
2M ago
8K
CBLL
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins
PremiumCompany Announcements
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins
3M ago
CBLL
Ceribell price target lowered to $25 from $28 at Canaccord
PremiumThe Fly
Ceribell price target lowered to $25 from $28 at Canaccord
3M ago
CBLL
Brandon Vazquez Reiterates Buy on Ceribell as Strong Commercial Execution and Rapid Pipeline Progress Support Attractive Long-Term Upside
PremiumRatings
Brandon Vazquez Reiterates Buy on Ceribell as Strong Commercial Execution and Rapid Pipeline Progress Support Attractive Long-Term Upside
3M ago
CBLL
Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained
PremiumRatingsCeribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained
3M ago
CBLL
Ceribell’s Earnings Call Signals Growth Over Profits
Premium
Company Announcements
Ceribell’s Earnings Call Signals Growth Over Profits
3M ago
CBLL
Ceribell reports Q1 EPS (52c), consensus (39c)
Premium
The Fly
Ceribell reports Q1 EPS (52c), consensus (39c)
3M ago
CBLL
Ceribell sees FY26 revenue $112M-$116M, consensus $113.18M
PremiumThe Fly
Ceribell sees FY26 revenue $112M-$116M, consensus $113.18M
3M ago
CBLL
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
PremiumCompany Announcements
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
4M ago
CBLL
Ceribell receives 510(k) premarket notification for brain monitor headband
PremiumThe Fly
Ceribell receives 510(k) premarket notification for brain monitor headband
4M ago
CBLL
Ceribell Earnings Call Highlights Strong Growth, Rising Costs
PremiumCompany Announcements
Ceribell Earnings Call Highlights Strong Growth, Rising Costs
5M ago
CBLL
Ceribell price target lowered to $28 from $30 at Canaccord
PremiumThe FlyCeribell price target lowered to $28 from $30 at Canaccord
5M ago
CBLL
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
Premium
Ratings
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
5M ago
CBLL
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
Premium
Ratings
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
5M ago
CBLL
Ceribell reports Q4 EPS (36c), consensus (41c)
PremiumThe Fly
Ceribell reports Q4 EPS (36c), consensus (41c)
5M ago
CBLL
Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M
PremiumThe Fly
Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M
5M ago
CBLL
CBLL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CBLL Earnings this Week: How Will it Perform?
5M ago
CBLL
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook
PremiumRatings
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook
6M ago
CBLL
Ceribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating
PremiumRatingsCeribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating
7M ago
CBLL
Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
Premium
Ratings
Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
7M ago
CBLL
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool
Premium
Company Announcements
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool
7M ago
8K
CBLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >